Literature DB >> 17578438

Endothelial cells in infantile haemangiomas originate from the child and not from the mother (a fluorescence in situ hybridization-based study).

S Régnier1, N Dupin, C Le Danff, M Wassef, O Enjolras, S Aractingi.   

Abstract

BACKGROUND: Infantile haemangiomas are benign vascular tumours of infancy of unknown origin. Their aetiological relationship to maternal cells has been questioned given that they develop during the neonatal period.
OBJECTIVES: As endothelial cells in the placenta may be of maternal or fetal origin, we questioned whether vascular haemangioma cells originated from fetal or maternal tissue.
METHODS: We aimed to detect, by using fluorescence in situ hybridization, maternal XX cells in the male XY tissue in four specimens of infantile haemangiomas obtained from boys. A sample of a female infantile haemangioma was used as a positive control and a male specimen of melanocytic naevus as a negative control.
RESULTS: In one case of infantile haemangioma, a single XX female - probably maternal - cell was detected in the infantile haemangioma. All the other cells from this male as well as the three other informative specimens were uniformly negative for XX cell detection.
CONCLUSION: Our results support the hypothesis that endothelial cells of infantile haemangiomas appear to derive from the child itself, in accordance with other studies.

Entities:  

Mesh:

Year:  2007        PMID: 17578438     DOI: 10.1111/j.1365-2133.2007.07922.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

Review 1.  Naturally acquired microchimerism.

Authors:  Hilary S Gammill; J Lee Nelson
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

Review 2.  Vasculogenesis in infantile hemangioma.

Authors:  Elisa Boscolo; Joyce Bischoff
Journal:  Angiogenesis       Date:  2009-05-10       Impact factor: 9.596

3.  Effects of propranolol and isoproterenol on infantile hemangioma endothelial cells in vitro.

Authors:  Yalin Zhu; Aerziguli Tuerxun; Yan Hui; Paride Abliz
Journal:  Exp Ther Med       Date:  2014-06-12       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.